Our findings are consistent with previous studies showing additional metabolic-cardiovascular-renal benefits of combined GLP-1RA and SGLT2i use in patients with T2D 26 , and suggest a promising role for adding GLP-1RA to SGLT2i therapy in patients with MASLD
A decade from now, the most popular GLP-1 drugs might advertise weight loss as a secondary benefit
To function, a muscle cell uses more energy than a fat cell, so, if you lose muscle mass, your body burns fewer calories overall, and daily calorie intake should be adjusted
Several simple strategies exist to create meaningful improvements in vitamin B12 absorption
A role for human skin-resident T cells in wound healing
The Ehlers-Danlos Societys own resources on orthopedic management acknowledge PRP as a useful non-surgical modality